Latest Breaking News On - Joel latham - Page 7 : comparemela.com

Review of IND Application for IHL-42X by US FDA has been completed; Clinical Trial for Patients with Obstructive Sleep Apnoea May Proceed

Review of IND Application for IHL-42X by US FDA has been completed; Clinical Trial for Patients with Obstructive Sleep Apnoea May Proceed
sina.com.hk - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from sina.com.hk Daily Mail and Mail on Sunday newspapers.

United statesJoel lathamEdison groupDrug administrationIncannex healthcare limited nasdaqIncannex healthcareAustralian stock exchangeContinuous positive airway pressureCompany investigational new drugIncannex healthcare limitedInvestigational new drugApnea hypopnea indexIncannex boardObstructive sleep apnoeaAmerican depository sharesSecurities litigation reform act

Public Announcement (NASDAQ: IXHL) (ASX

Public Announcement Incannex to Conduct Shareholder Information Events Regarding Redomicile from Australia to United States . -Today at 06:12 am- MarketScreener

United statesWestern australiaNew south walesJoel lathamIncannex healthcareEdison groupAustralian stock exchangeIncannex healthcare limited nasdaqIncannex healthcare limitedPublic announcementHealthcare limitedPerson shareholder meetingsLocation informationShareholder participationIncannex boardRialto south tower

Incannex Healthcare : Clarion Clinics Begins Accepting Registrations for Psychedelic Treatment Interest as Part of Pre-Screening in Readiness for Opening

Clarion Clinics Begins Accepting Registrations for Psychedelic Treatment Interest as Part of Pre-Screening in Readiness for Opening Highlights: .

New south walesUnited statesJoel lathamPaul liknaitzkySean ocarrollSuresh sundramPeter widdows incannexTherapeutic goods administrationEdison groupIncannex healthcare ltd nasdaqZealand college of psychiatristsIncannex healthcareClarion clinics group pty ltdAustralian stock exchangeClarion clinics begins accepting registrationsPsychedelic treatment interest

Incannex Healthcare connects superannuation shareholders with independent advice amid US redomiciliation

Ahead of its intended transition to the Nasdaq, Incannex Healthcare Ltd (ASX:IHL, NASDAQ:IXHL) is offering shareholders the chance to engage with an.

United statesJuly incannexJoel lathamNasdaq incannex healthcare ltdIncannex healthcare ltd

Incannex Healthcare June 2023 Quarterly Activities Report and Appendix 4C Cash Flow Statement

28.07.2023 - MELBOURNE, Australia, July 28, 2023 (GLOBE NEWSWIRE) - Clinical stage pharmaceutical development company, Incannex Healthcare Limited (ASX: IHL) (NASDAQ: IXHL), (‘Incannex’ or the ‘Company’), is pleased to provide its quarterly activities report .

South australiaUnited statesNew zealandJoel lathamRedomiciling incannexPeter widdowsApril incannexDrug administrationEarly phase clinical researchIncannex healthcareClinical researchIv clinical researchQuest pharmaceutical servicesClarion clinics group pty ltdHuman research ethics committeeClarion clinics group